Goldman Sachs’s Organon & Co OGN Stock Holding History

Goldman Sachs’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$279K	–	6141
2022 Q4	$279K	Hold	10,000	–	–	﹤0.01%	5172
2022 Q3	$234K	Hold	10,000	–	–	﹤0.01%	5411
2022 Q2	$338K	Hold	10,000	–	–	﹤0.01%	5348
2022 Q1	$349K	Sell	10,000 -17,750	-64%	-$607K	﹤0.01%	5577
2021 Q4	$845K	Hold	27,750	–	–	﹤0.01%	4997
2021 Q3	$910K	Sell	27,750 -2,570	-8%	-$82.2K	﹤0.01%	4821
2021 Q2	$917K	Buy	+30,320	New	+$998K	﹤0.01%	4833

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Goldman Sachs's OGN Position: Q2 2026 in Review

Goldman Sachs increased its Organon & Co (OGN) stake by 224% in Q2 2026, buying an estimated $43M and bringing the position to 5,199,002 shares worth $70.4M. The position accounts for 0.01% of the portfolio, ranked #1512.

Goldman Sachs first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. 632 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Goldman Sachs held 5,199,002 shares of Organon & Co worth $70.4M as of Q2 2026.
Goldman Sachs bought 3,593,677 Organon & Co shares in Q2 2026, an estimated $43M.
Organon & Co made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1512 holding.
Goldman Sachs first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
632 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.